Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corbus Pharmaceuticals Holdings (CRBP) Gains from Investment Securities (2016 - 2025)

Corbus Pharmaceuticals Holdings has reported Gains from Investment Securities over the past 10 years, most recently at $11000.0 for Q4 2023.

  • For Q4 2023, Gains from Investment Securities fell 92.98% year-over-year to $11000.0; the TTM value through Dec 2023 reached $69531.0, down 54.59%, while the annual FY2024 figure was -$212000.0, 129.91% down from the prior year.
  • Gains from Investment Securities for Q4 2023 was $11000.0 at Corbus Pharmaceuticals Holdings, down from $28576.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $6.1 million in Q3 2021 and troughed at -$90421.0 in Q4 2021.
  • A 5-year average of $2.4 million and a median of $431294.5 in 2022 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: soared 61692.53% in 2019 and later tumbled 195.59% in 2021.
  • Year by year, Gains from Investment Securities stood at $4.7 million in 2019, then plummeted by 98.0% to $94593.0 in 2020, then tumbled by 195.59% to -$90421.0 in 2021, then soared by 273.3% to $156704.0 in 2022, then plummeted by 92.98% to $11000.0 in 2023.
  • Business Quant data shows Gains from Investment Securities for CRBP at $11000.0 in Q4 2023, $28576.0 in Q3 2023, and $25659.0 in Q2 2023.